CRUSH!!MDS - A phase 2 study of SGI-110 in Philadelphia-negative myeloproliferative neoplasms
1 Visualizzazioni
administrator
07/29/23
Dr. Pinkal Desai Discusses a Clinical Trial of SGI-110 for Patients with Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Chronic Myelomonocytic Leukemia to learn more & participate in a clinical trial visit crushmds.org
Mostra di piรน
Commenti su Facebook
Nessun commento trovato